Should chemoradiotherapy be standard to maximise cure in localised gastro-oesophageal cancer?

Lancet Oncol. 2022 Jul;23(7):847-849. doi: 10.1016/S1470-2045(21)00753-1.
No abstract available

MeSH terms

  • Chemoradiotherapy / adverse effects
  • Esophageal Neoplasms* / drug therapy
  • Esophageal Neoplasms* / radiotherapy
  • Humans
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / radiotherapy